Evolution of the prevalence and incidence of consumption of antidepressants in a Spanish region (2002-2007)

Mental Health in Family Medicine

Volumn 7, Issue 1, 2010, Pages 9-15

  Serna, Catalina ^a,b   Cruz, Inés ^c   Galván, Leonardo ^c   Real, Jordi ^c   Gascó, Eduardo ^b   Soler González, Jorge ^a,b  

^a Universitat de Lleida Facultat de Medicina Sabadell   (Spain)

^b INSTITUT CATALÀ DE LA SALUT   (Spain)

^c IDIAP Jordi Gol ICS ^*  (Spain)

Author keywords

Antidepressant consumption; Prevalence; Primary care; Psychological treatments

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; DEPRESSION; DRUG USE; FEMALE; GENDER; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRESCRIPTION; PRIMARY MEDICAL CARE; SPAIN;

EID: 77955443485     PISSN: 1756834X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Serna Arnáiz C, Galván Santiago L, Gascó Eguíluz E, Santafé Soler P, Martín Gracia E and Vila Parrot T. Evolution in consumption of anti-depressants during the years 2002 to 2004. Atencion Primaria 2006;38:456-60.
2. Haro JM, Palacín C, Bernal Met al. Grupo ESEMeD-España. Prevalence of mental disorders and associated factors: results from the ESEMeD-Spain study. Medicina Clinica 2006;126:445-51.
3. Aragones E, Pinol JL, Labad A, Folch S and Melich N. Detection and management of depressive disorders in primary care in Spain. International Journal of Psychiatry in Medicine 2004;34:332-43.
4. Nomenclator Digitalis. Madrid: INSALUD, 2000. Available at: www.msc.es/profesionales/farmacia/presentacion.htm
5. Ley 14/1986. Ley General de Sanidad. BOE núm. 112, 24 April 1986.
6. Sartor F and Walckiers D. Estimate of disease prevalence using drug consumption data. American Journal of Epidemiology 1995;141:782-7.
7. Von Korff M, Wagner EH and Saunders K. A chronic disease score from automated pharmacy data. Journal of Clinical Epidemiology 1992;45:197-203.
8. Alonso J, Angermeyer MC, Bernert S et al. Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatrica Scandinavica 2004;420(Suppl.):55- 64.
9. Isacsson G, Boethius G, Henriksson S, Jones JK and Bergman U. Selective serotonin reuptake inhibitors have broadened the utilization of antidepressant treatment in accordance with recommendations. Findings from a Swedish prescription database. Journal of Affective Disorders 1999;53:15-22.
10. Ortiz LoboA and Lozano Serran C. El incremento en la prescripción de antidepresivos. Atencion Primaria 2005;35:152-5.
11. Raymond C, Morgan S and Caetano P. Antidepressant utilization in British Columbia from 1996 to 2004: increasing prevalence but not incidence. Psychiatric Services 2007;58:79-84.
12. Sans S, Paluzie G, Puig T, Balaña L and Balaguer-Vintró I. Prevalencia del consumo de medicamentos en la población adulta de Cataluña. Gaceta Sanitaria 2002;16:121-30.
13. Ruiz-Cantero M, Verdú-Delgado M. Sesgo de género en el esfuerzo terapéutico. Gaceta Sanitaria 2004;18:118-25.
14. García MM, Fernández I and Mateo I. Las mujeres como usuarias de los servicios sanitarios. In: Aguiar F, García I, Pérez M (eds) La Situación Social de las Mujeres en Andalucía 1990-2000. Sevilla: Instituto Andaluz de la Mujer, Consejería de la Presidencia, 2001, pp. 25-37.
15. Friedan B. La Mística de la Feminidad. Madrid: Jucar, 1974.
16. National Institute for Clinical Excellence. Management of Depression in Primary and Secondary Care. London: National Institute for Clinical Excellence, 2004. guidance.nice.org.uk/CG23
17. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ and Johnson BT. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PloS Medicine 2008;5:45.
18. Mottram P, Wilson K and Strobl J. Antidepressants for depressed elderly. The Cochrane Library 2008;3:11-16.
19. Garrison GD and Levin GM. Factors affecting prescribing of the newer antidepressants. Annals of Pharmacotherapy 2000;34:10-14.
20. Holma IA, Holma KM, Melartin TK and Isometsa ET. Maintenance pharmacotherapy for recurrent major depressive disorder: five-year follow-up study. British Journal of Psychiatry 2008;193:163-4.
21. Moore M, Ming Yuen H, Dunn N, Mullee MA, Maskell J and Kendrick T. Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database. British Medical Journal 2009;339:b3999.
22. Olfson M, Marcus SC,Druss B, Ellinson L, Tanielian T and Pincus HA. National trends in the outpatient treatment of depression. Journal of the American Medical Association 2002;287:203-9.
23. Kendrick T, King F Albertella L and Smith PWF. GP treatment decisions for patients with depression: an observational study. British Journal of General Practice 2005;55:280-6.
24. National Institute for Clinical Excellence. Depression: management of depression in primary and secondary care. Clinical Practice Guideline No. 23. London: National Institute for Clinical Excellence; 2004.